PRESS-RELEASE ·Filed May 1, 2026
Press release: fda
Actionable Insight • Neutral
Routine conference participation with no material data releases expected. Monitor for any significant data readouts or regulatory updates in future filings.
Final — all horizons settled through T+60d
PHAT ▼ -2.91% at T+60d
NEUTRAL call ✗ call lost -2.91% · α vs SPY -5.98% · entry $12.01 → $11.66
T+1d
+7.16%
call +7.16% · α +7.50%
$12.87
settled 5mo ago
T+5d
+1.83%
call +1.83% · α -0.52%
$12.23
settled 5mo ago
T+20d
-23.06%
call -23.06% · α -28.35%
$9.24
settled 4mo ago
T+60d
-2.91%
call -2.91% · α -5.98%
$11.66
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Phathom Pharmaceuticals announced its participation in the Digestive Disease Week (DDW) 2026 annual meeting, including a product theater presentation for VOQUEZNA and three poster presentations. This is a routine conference attendance with no material financial or regulatory impact.
Key Facts
- Phathom will participate in DDW 2026 (May 2-5, Chicago) with a product theater presentation on VOQUEZNA on May 4.
- The company will present three posters covering clinical, patient-reported, and real-world data for VOQUEZNA in GERD.
- Poster abstracts will be available on the company website after the meeting.
Financial Impact
No financial impact from this announcement.
Risk Factors
- No specific risks identified from this announcement.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (17 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3285869 |
8 reports for PHAT
67% Hit rate best @ T+20▲ +12.86%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 30, 2026 9w ago | 8-K | $9.03 $8.94 | ▼ −1.00% | ▼ −4.96% | $6.92 (−23.37%) |
Jul 30, 2026 9w ago | Press Release | $9.03 $8.94 | ▲ +1.00% | ▲ +4.96% | $6.92 (+23.37%) |
Jul 20, 2026 10w ago | Press Release | $10.65 $9.28 | ▲ +12.86% | ▲ +16.98% | $6.92 (+35.02%) |
May 20, 2026 19w ago | Press Release | $11.87 $10.88 | ▼ −8.34% | ▼ −9.08% | $6.92 (−41.70%) |
May 1, 2026 22w ago | Press Release | $12.01 $9.24 | ▼ −23.06% | ▼ −28.35% | $6.92 (−42.38%) |
Apr 30, 2026 22w ago | Press Release | $11.20 $10.32 | ▼ −7.86% | ▼ −12.82% | $6.92 (−38.21%) |
Apr 7, 2026 25w ago | DEFA14A | $11.55 $12.87 | ▲ +11.43% | ▲ +1.65% | $6.92 (−40.09%) |
Feb 26, 2026 31w ago | 8-K | $13.56 $10.79 | ▼ −20.43% | ▼ −14.03% | $6.92 (−48.97%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Mon (65h 2m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access